Navigation Links
Summary Judgment Granted for SEROQUEL(R) Patent Litigation
Date:7/1/2008

ure, tachycardia, diaphoresis, and cardiac dysrhythmia). Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure. The management of NMS should include immediate discontinuation of antipsychotic drugs.

Leukopenia, neutropenia, and agranulocytosis (including fatal cases), have been reported temporally related to atypical antipsychotics, including SEROQUEL. Patients with a pre-existing low white blood cell (WBC) count or a history of drug induced leukopenia/neutropenia should have their complete blood count monitored frequently during the first few months of therapy. In these patients, SEROQUEL should be discontinued at the first sign of a decline in WBC absent other causative factors. Patients with neutropenia should be carefully monitored, and SEROQUEL should be discontinued in any patient if the absolute neutrophil count is < 1000/mm3.

Tardive dyskinesia (TD), a potentially irreversible syndrome of involuntary dyskinetic movements, may develop in patients treated with antipsychotic drugs. The risk of developing TD and the likelihood that it will become irreversible are believed to increase as the duration of treatment and total cumulative dose of antipsychotic drugs administered to the patient increase. TD may remit, partially or completely, if antipsychotic treatment is withdrawn. SEROQUEL should be prescribed in a manner that is most likely to minimize the occurrence of TD.

Warnings and Precautions also include the risk of orthostatic hypotension, cataracts, seizures, hyperlipidemia, and possibility of suicide attempts. Examination of the lens by methods adequate to detect cataract formation, such as slit lamp exam or other appropriately sensitive methods, is recommended at initiation of treatment or shortly thereafter, and at 6-month intervals during chronic treatment. The possibility of a suicide attempt is inherent in schizophrenia, and close supervision of high risk patients sho
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
2. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
3. Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion
4. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
5. Par Pharmaceutical Provides Summary of Analyst/Investor Day
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
8. Exercising judgment: The psychology of fitness
9. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
10. St. Davids HealthCare Granted the States Top Honor for Quality and Performance Excellence
11. MonoSol Rx Granted US Patent for Thin Film Manufacturing Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... Dr. Andrew Campbell, one of the ... expansion of Quintessa Aesthetic Center into a third location ... W307 N1497 Golf Road in Suite 200 and will ... the new Delafield location will offer a variety of ... Botox, filler injectables , micro laser peels, chemical ...
(Date:11/28/2014)... Miami's Plastic Surgery of the Face recently introduced ... Jeffrey Epstein is excited to offer patients the ... the site is uniquely designed for easing viewing on ... of all prospective rhinoplasty patients research upcoming procedures online. ... with smartphones, tablets, and laptops, as well as the ...
(Date:11/28/2014)... The Alternative Health Therapies ... five years. The industry has been buoyed by ... either alternative to conventional Western medicine or complementary ... David Whytcross, “industry revenue has been further boosted ... insurance membership.” Meanwhile, improving economic conditions following the ...
(Date:11/28/2014)... Written and narrated by award winning author ... the “The Happiest Man In the World: Life Lessons ... how and why Project C.U.R.E. came to be. , Raised ... and the Reverend Richard W. Jackson, Dr. Jackson exceeded his ... but realized that he wasn’t happy. Prompted by this realization, ...
(Date:11/28/2014)... (HealthDay News) -- Planning on seconds at Thanksgiving Day ... clinically known as gastroesophageal reflux disease (GERD) -- a few ... an ear, nose and throat specialist at Lenox Hill Hospital ... manage GERD on Thanksgiving: Pace yourself. ... small meals throughout the day. It,s also a good idea ...
Breaking Medicine News(10 mins):Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2
... watched such fare more likely to act out at 7, ... Preschool boys exposed to violent television -- even cartoons -- ... warn. , Their findings don,t definitively prove that TV makes ... fare, according to the researchers. But the link does appear ...
... Fla. -- If you go to the hospital within one ... heart attack, your chances of getting proper treatment are nearly ... hours before seeking treatment, according to results presented today at ... , This research should emphasize to patients that getting help ...
... WASHINGTON, Nov. 5 For the next two ... will be in wildfire-ravaged,areas of Southern California, attempting ... they need. The first stop will,be from 10 ... Catholic Community Church,in Fallbrook, CA., This marks ...
... Inc., the leading,provider of Web-based employee performance and ... 2007 was the organization,s strongest,to date. The organization ... percent year-over-year revenue growth over the third quarter ... high priority for our,organization and this new solution ...
... a cancer-prevention gene in the response to drug treatment for ... also known as the guardian of the genome, is known ... the gene are associated with a high incidence of cancer ... to tumours. , In childhood cancers such as neuroblastoma, p53 ...
... temperatures may help keep vessels constricted, experts say , , MONDAY, ... has a chill factor: Hypertension is harder to control in ... to be presented Monday at the American Heart Association annual ... has been noted for decades that people,s blood pressure tends ...
Cached Medicine News:Health News:TV Violence May Spur Aggression in Boys 2Health News:TV Violence May Spur Aggression in Boys 3Health News:Mayo Clinic identifies new risk factor for heart attack patients 2Health News:'Help is Here Express' Bus Tour in California to Help Fire Victims Access Prescription Medicines 2Health News:'Help is Here Express' Bus Tour in California to Help Fire Victims Access Prescription Medicines 3Health News:Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue 2Health News:Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue 3Health News:Blood Pressure Tougher to Tame in Winter 2
(Date:11/28/2014)... , Nov. 28, 2014 Chinese magnesium alloy ... that its biodegradable magnesium alloy bone fixation screw has ... medical apparatus and instrument and that the company ... an interview with Science and Technology Daily ... the company chairman and founder, Professor Li Yangde ...
(Date:11/26/2014)... , Nov. 26, 2014  Thoratec Corporation (NASDAQ: ... mechanical circulatory support therapies to save, support and restore ... two upcoming investor conferences. On Tuesday, December ... Annual Piper Jaffray Healthcare Conference.  D. Keith ... an update on the company beginning at 11:30 a.m., ...
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Genomic Health, ... Kim Popovits , Chairman, Chief Executive Officer and President, ... Jaffray Healthcare Conference at The New York Palace Hotel ... December 3 at 11:30 am Eastern Time (ET). ... of the conference call, go to the  Investor Relations ...
Breaking Medicine Technology:Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4Thoratec Announces Presentations At Investor Conferences For December 2014 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3
... (OTC Bulletin Board: CGNH ) announced today that ... 2 Class B common stockholders a "Stockholder Questionnaire," which the ... count of the Company,s shares currently held in "street ... If you have not received the Stockholder Questionnaires via ...
... VILLAGE, Nev., March 8, 2011 PDL BioPharma, Inc. (PDL) (Nasdaq: ... rate for its 2.00% Convertible Senior Notes due February 15, 2012 ... 15, 2015 (the 2015 Notes) effective March 7, 2011, in connection ... to all stockholders who own shares of PDL on March 8, ...
Cached Medicine Technology:CardioGenics Requests Stockholders to Participate in Stockholder Questionnaires 2PDL BioPharma Announces Conversion Rate Adjustments for 2.00% Convertible Senior Notes Due February 15, 2012 and 2.875% Convertible Senior Notes Due February 15, 2015 2
... offers improved ergonomics for today's exacting ... grippy finger rest and the large ... efficiency. Finnpipette Digitals also feature soft-touch ... (pat. pend.) and super blow-out for ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features: Eppendorf "pipette/tip" ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 100-1,000 microliter range....
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,409-7) or contact custom...
Medicine Products: